FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

778920003: Product containing only dasabuvir and ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3739463015 Dasabuvir and ombitasvir and paritaprevir and ritonavir only product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3739464014 Product containing only dasabuvir and ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5556281000241114 produit contenant seulement du dasabuvir et de l'ombitasvir et du paritaprévir et du ritonavir sous forme orale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dasabuvir and ombitasvir and paritaprevir and ritonavir only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ritonavir (substance) true Inferred relationship Some 1
Dasabuvir and ombitasvir and paritaprevir and ritonavir only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ombitasvir true Inferred relationship Some 2
Dasabuvir and ombitasvir and paritaprevir and ritonavir only product in oral dose form Has manufactured dose form Oral dose form true Inferred relationship Some
Dasabuvir and ombitasvir and paritaprevir and ritonavir only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Paritaprevir (substance) true Inferred relationship Some 4
Dasabuvir and ombitasvir and paritaprevir and ritonavir only product in oral dose form Count of base of active ingredient quatre false Inferred relationship Some
Dasabuvir and ombitasvir and paritaprevir and ritonavir only product in oral dose form Is a Dasabuvir- and ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form true Inferred relationship Some
Dasabuvir and ombitasvir and paritaprevir and ritonavir only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dasabuvir (substance) true Inferred relationship Some 3
Dasabuvir and ombitasvir and paritaprevir and ritonavir only product in oral dose form Is a Dasabuvir and ombitasvir and paritaprevir and ritonavir only product true Inferred relationship Some
Dasabuvir and ombitasvir and paritaprevir and ritonavir only product in oral dose form Plays role Antiretroviral therapeutic role false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start